Guardant Health, Inc. (FRA:5GH)

Guardant Health Statistics

Total Valuation

Guardant Health has a market cap or net worth of EUR 11.62 billion. The enterprise value is 12.26 billion.

Market Cap	11.62B
Enterprise Value	12.26B

Important Dates

The next estimated earnings date is Friday, February 20, 2026.

Earnings Date	Feb 20, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	128.34M
Shares Outstanding	n/a
Shares Change (YoY)	+2.22%
Shares Change (QoQ)	+0.56%
Owned by Insiders (%)	3.84%
Owned by Institutions (%)	96.73%
Float	123.41M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	15.10
PB Ratio	-38.45
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-36.06
EV / Sales	15.79
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-54.85

Financial Position

The company has a current ratio of 3.50

Current Ratio	3.50
Quick Ratio	2.94
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-5.06
Interest Coverage	-131.57

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-19.64%
Return on Invested Capital (ROIC)	-24.56%
Return on Capital Employed (ROCE)	-42.54%
Revenue Per Employee	382,716
Profits Per Employee	-169,098
Employee Count	2,021
Asset Turnover	0.64
Inventory Turnover	4.02

Taxes

In the past 12 months, Guardant Health has paid 1.01 million in taxes.

Income Tax	1.01M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +184.09% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+184.09%
50-Day Moving Average	68.36
200-Day Moving Average	48.56
Relative Strength Index (RSI)	73.83
Average Volume (20 Days)	30

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.26

Income Statement

In the last 12 months, Guardant Health had revenue of EUR 769.26 million and -339.89 million in losses. Loss per share was -2.74.

Revenue	769.26M
Gross Profit	490.47M
Operating Income	-377.00M
Pretax Income	-338.88M
Net Income	-339.89M
EBITDA	-342.79M
EBIT	-377.00M
Loss Per Share	-2.74

Balance Sheet

The company has 494.35 million in cash and 1.13 billion in debt, giving a net cash position of -636.13 million.

Cash & Cash Equivalents	494.35M
Total Debt	1.13B
Net Cash	-636.13M
Net Cash Per Share	n/a
Equity (Book Value)	-302.12M
Book Value Per Share	-2.42
Working Capital	504.53M

Cash Flow

In the last 12 months, operating cash flow was -189.98 million and capital expenditures -33.52 million, giving a free cash flow of -223.50 million.

Operating Cash Flow	-189.98M
Capital Expenditures	-33.52M
Free Cash Flow	-223.50M
FCF Per Share	n/a

Margins

Gross margin is 63.76%, with operating and profit margins of -49.01% and -44.18%.

Gross Margin	63.76%
Operating Margin	-49.01%
Pretax Margin	-44.05%
Profit Margin	-44.18%
EBITDA Margin	-44.56%
EBIT Margin	-49.01%
FCF Margin	n/a

Dividends & Yields

Guardant Health does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.22%
Shareholder Yield	-2.22%
Earnings Yield	-2.93%
FCF Yield	-1.92%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Guardant Health has an Altman Z-Score of -1.08 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.08
Piotroski F-Score	4